Brief: FDA Approved Nuzolvence (Zoliflodacin) To Treat Uncomplicated Urogenital Gonorrhea
12/12/2025 18:25
Dec 12 (Reuters) - FDA: FDA: TODAY APPROVED NUZOLVENCE (ZOLIFLODACIN) GRANULES THAT DISSOLVE IN WATER TO TREAT UNCOMPLICATED UROGENITAL GONORRHEA - WEBSITE Further company coverage: INVA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innoviva
See all newsInnoviva, Inc. reports results for the quarter ended June 30 - Earnings Summary
Innoviva Q2 revenue rises on higher net product sales
Brief: Innoviva Q2 Royalty Revenue USD 56.334 Million
Brief: Nortiva Bio Launches To Develop Long-Acting Oral Medicines
Brief: Innoviva Q1 Royalty Revenue USD 55.167 Million